Request for Covid-19 Impact Assessment of this Report
The United States Non-Steroidal Anti-Inflammatory API market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Non-Steroidal Anti-Inflammatory API market, reaching US$ million by the year 2028. As for the Europe Non-Steroidal Anti-Inflammatory API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Non-Steroidal Anti-Inflammatory API players cover Luan Pharmaceutical, Basf Company, Fengyuan Pharmaceutical, and Xinhua Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Steroidal Anti-Inflammatory API market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxapzin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medical Pharmaceutical
Scientific Research
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Luan Pharmaceutical
Basf Company
Fengyuan Pharmaceutical
Xinhua Pharmaceutical
Changshu Huagang Pharmaceutical
Hebei Jiheng Group
Zhejiang Kangle Group
Hebei Jingye Medical Technology
Hunan Middle-south Pharmaceutical
Mallinckrodt Pharmaceuticals
IOL
Novacyl
Granules India Limited
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non-Steroidal Anti-Inflammatory API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non-Steroidal Anti-Inflammatory API by Country/Region, 2017, 2022 & 2028
2.2 Non-Steroidal Anti-Inflammatory API Segment by Type
2.2.1 Aspirin
2.2.2 Ibuprofen
2.2.3 Naproxen
2.2.4 Diclofenac
2.2.5 Oxapzin
2.2.6 Others
2.3 Non-Steroidal Anti-Inflammatory API Sales by Type
2.3.1 Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)
2.3.2 Global Non-Steroidal Anti-Inflammatory API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non-Steroidal Anti-Inflammatory API Sale Price by Type (2017-2022)
2.4 Non-Steroidal Anti-Inflammatory API Segment by Application
2.4.1 Medical Pharmaceutical
2.4.2 Scientific Research
2.5 Non-Steroidal Anti-Inflammatory API Sales by Application
2.5.1 Global Non-Steroidal Anti-Inflammatory API Sale Market Share by Application (2017-2022)
2.5.2 Global Non-Steroidal Anti-Inflammatory API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non-Steroidal Anti-Inflammatory API Sale Price by Application (2017-2022)
3 Global Non-Steroidal Anti-Inflammatory API by Company
3.1 Global Non-Steroidal Anti-Inflammatory API Breakdown Data by Company
3.1.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales by Company (2020-2022)
3.1.2 Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Company (2020-2022)
3.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue by Company (2020-2022)
3.2.1 Global Non-Steroidal Anti-Inflammatory API Revenue by Company (2020-2022)
3.2.2 Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Company (2020-2022)
3.3 Global Non-Steroidal Anti-Inflammatory API Sale Price by Company
3.4 Key Manufacturers Non-Steroidal Anti-Inflammatory API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Steroidal Anti-Inflammatory API Product Location Distribution
3.4.2 Players Non-Steroidal Anti-Inflammatory API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Steroidal Anti-Inflammatory API by Geographic Region
4.1 World Historic Non-Steroidal Anti-Inflammatory API Market Size by Geographic Region (2017-2022)
4.1.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue by Geographic Region
4.2 World Historic Non-Steroidal Anti-Inflammatory API Market Size by Country/Region (2017-2022)
4.2.1 Global Non-Steroidal Anti-Inflammatory API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue by Country/Region
4.3 Americas Non-Steroidal Anti-Inflammatory API Sales Growth
4.4 APAC Non-Steroidal Anti-Inflammatory API Sales Growth
4.5 Europe Non-Steroidal Anti-Inflammatory API Sales Growth
4.6 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Growth
5 Americas
5.1 Americas Non-Steroidal Anti-Inflammatory API Sales by Country
5.1.1 Americas Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022)
5.1.2 Americas Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022)
5.2 Americas Non-Steroidal Anti-Inflammatory API Sales by Type
5.3 Americas Non-Steroidal Anti-Inflammatory API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Steroidal Anti-Inflammatory API Sales by Region
6.1.1 APAC Non-Steroidal Anti-Inflammatory API Sales by Region (2017-2022)
6.1.2 APAC Non-Steroidal Anti-Inflammatory API Revenue by Region (2017-2022)
6.2 APAC Non-Steroidal Anti-Inflammatory API Sales by Type
6.3 APAC Non-Steroidal Anti-Inflammatory API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory API by Country
7.1.1 Europe Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022)
7.1.2 Europe Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022)
7.2 Europe Non-Steroidal Anti-Inflammatory API Sales by Type
7.3 Europe Non-Steroidal Anti-Inflammatory API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Steroidal Anti-Inflammatory API by Country
8.1.1 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022)
8.2 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Type
8.3 Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Steroidal Anti-Inflammatory API
10.3 Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory API
10.4 Industry Chain Structure of Non-Steroidal Anti-Inflammatory API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Steroidal Anti-Inflammatory API Distributors
11.3 Non-Steroidal Anti-Inflammatory API Customer
12 World Forecast Review for Non-Steroidal Anti-Inflammatory API by Geographic Region
12.1 Global Non-Steroidal Anti-Inflammatory API Market Size Forecast by Region
12.1.1 Global Non-Steroidal Anti-Inflammatory API Forecast by Region (2023-2028)
12.1.2 Global Non-Steroidal Anti-Inflammatory API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Steroidal Anti-Inflammatory API Forecast by Type
12.7 Global Non-Steroidal Anti-Inflammatory API Forecast by Application
13 Key Players Analysis
13.1 Luan Pharmaceutical
13.1.1 Luan Pharmaceutical Company Information
13.1.2 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
13.1.3 Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Luan Pharmaceutical Main Business Overview
13.1.5 Luan Pharmaceutical Latest Developments
13.2 Basf Company
13.2.1 Basf Company Company Information
13.2.2 Basf Company Non-Steroidal Anti-Inflammatory API Product Offered
13.2.3 Basf Company Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Basf Company Main Business Overview
13.2.5 Basf Company Latest Developments
13.3 Fengyuan Pharmaceutical
13.3.1 Fengyuan Pharmaceutical Company Information
13.3.2 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
13.3.3 Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fengyuan Pharmaceutical Main Business Overview
13.3.5 Fengyuan Pharmaceutical Latest Developments
13.4 Xinhua Pharmaceutical
13.4.1 Xinhua Pharmaceutical Company Information
13.4.2 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
13.4.3 Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Xinhua Pharmaceutical Main Business Overview
13.4.5 Xinhua Pharmaceutical Latest Developments
13.5 Changshu Huagang Pharmaceutical
13.5.1 Changshu Huagang Pharmaceutical Company Information
13.5.2 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
13.5.3 Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Changshu Huagang Pharmaceutical Main Business Overview
13.5.5 Changshu Huagang Pharmaceutical Latest Developments
13.6 Hebei Jiheng Group
13.6.1 Hebei Jiheng Group Company Information
13.6.2 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Product Offered
13.6.3 Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hebei Jiheng Group Main Business Overview
13.6.5 Hebei Jiheng Group Latest Developments
13.7 Zhejiang Kangle Group
13.7.1 Zhejiang Kangle Group Company Information
13.7.2 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Product Offered
13.7.3 Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Zhejiang Kangle Group Main Business Overview
13.7.5 Zhejiang Kangle Group Latest Developments
13.8 Hebei Jingye Medical Technology
13.8.1 Hebei Jingye Medical Technology Company Information
13.8.2 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Product Offered
13.8.3 Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hebei Jingye Medical Technology Main Business Overview
13.8.5 Hebei Jingye Medical Technology Latest Developments
13.9 Hunan Middle-south Pharmaceutical
13.9.1 Hunan Middle-south Pharmaceutical Company Information
13.9.2 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
13.9.3 Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hunan Middle-south Pharmaceutical Main Business Overview
13.9.5 Hunan Middle-south Pharmaceutical Latest Developments
13.10 Mallinckrodt Pharmaceuticals
13.10.1 Mallinckrodt Pharmaceuticals Company Information
13.10.2 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Product Offered
13.10.3 Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.10.5 Mallinckrodt Pharmaceuticals Latest Developments
13.11 IOL
13.11.1 IOL Company Information
13.11.2 IOL Non-Steroidal Anti-Inflammatory API Product Offered
13.11.3 IOL Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 IOL Main Business Overview
13.11.5 IOL Latest Developments
13.12 Novacyl
13.12.1 Novacyl Company Information
13.12.2 Novacyl Non-Steroidal Anti-Inflammatory API Product Offered
13.12.3 Novacyl Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Novacyl Main Business Overview
13.12.5 Novacyl Latest Developments
13.13 Granules India Limited
13.13.1 Granules India Limited Company Information
13.13.2 Granules India Limited Non-Steroidal Anti-Inflammatory API Product Offered
13.13.3 Granules India Limited Non-Steroidal Anti-Inflammatory API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Granules India Limited Main Business Overview
13.13.5 Granules India Limited Latest Developments
14 Research Findings and Conclusion
Table 1. Non-Steroidal Anti-Inflammatory API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non-Steroidal Anti-Inflammatory API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Aspirin
Table 4. Major Players of Ibuprofen
Table 5. Major Players of Naproxen
Table 6. Major Players of Diclofenac
Table 7. Major Players of Oxapzin
Table 8. Major Players of Others
Table 9. Global Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)
Table 10. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)
Table 11. Global Non-Steroidal Anti-Inflammatory API Revenue by Type (2017-2022) & ($ million)
Table 12. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Type (2017-2022)
Table 13. Global Non-Steroidal Anti-Inflammatory API Sale Price by Type (2017-2022) & (US$/Kg)
Table 14. Global Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)
Table 15. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)
Table 16. Global Non-Steroidal Anti-Inflammatory API Revenue by Application (2017-2022)
Table 17. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Application (2017-2022)
Table 18. Global Non-Steroidal Anti-Inflammatory API Sale Price by Application (2017-2022) & (US$/Kg)
Table 19. Global Non-Steroidal Anti-Inflammatory API Sales by Company (2020-2022) & (Tons)
Table 20. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Company (2020-2022)
Table 21. Global Non-Steroidal Anti-Inflammatory API Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Company (2020-2022)
Table 23. Global Non-Steroidal Anti-Inflammatory API Sale Price by Company (2020-2022) & (US$/Kg)
Table 24. Key Manufacturers Non-Steroidal Anti-Inflammatory API Producing Area Distribution and Sales Area
Table 25. Players Non-Steroidal Anti-Inflammatory API Products Offered
Table 26. Non-Steroidal Anti-Inflammatory API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Non-Steroidal Anti-Inflammatory API Sales by Geographic Region (2017-2022) & (Tons)
Table 30. Global Non-Steroidal Anti-Inflammatory API Sales Market Share Geographic Region (2017-2022)
Table 31. Global Non-Steroidal Anti-Inflammatory API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Non-Steroidal Anti-Inflammatory API Sales by Country/Region (2017-2022) & (Tons)
Table 34. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Country/Region (2017-2022)
Table 35. Global Non-Steroidal Anti-Inflammatory API Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022) & (Tons)
Table 38. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Country (2017-2022)
Table 39. Americas Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country (2017-2022)
Table 41. Americas Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)
Table 42. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)
Table 43. Americas Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)
Table 44. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)
Table 45. APAC Non-Steroidal Anti-Inflammatory API Sales by Region (2017-2022) & (Tons)
Table 46. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Region (2017-2022)
Table 47. APAC Non-Steroidal Anti-Inflammatory API Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Non-Steroidal Anti-Inflammatory API Revenue Market Share by Region (2017-2022)
Table 49. APAC Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)
Table 50. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)
Table 51. APAC Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)
Table 52. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)
Table 53. Europe Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022) & (Tons)
Table 54. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Country (2017-2022)
Table 55. Europe Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country (2017-2022)
Table 57. Europe Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)
Table 58. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)
Table 59. Europe Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)
Table 60. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Country (2017-2022) & (Tons)
Table 62. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Type (2017-2022) & (Tons)
Table 66. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales by Application (2017-2022) & (Tons)
Table 68. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Non-Steroidal Anti-Inflammatory API
Table 70. Key Market Challenges & Risks of Non-Steroidal Anti-Inflammatory API
Table 71. Key Industry Trends of Non-Steroidal Anti-Inflammatory API
Table 72. Non-Steroidal Anti-Inflammatory API Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Non-Steroidal Anti-Inflammatory API Distributors List
Table 75. Non-Steroidal Anti-Inflammatory API Customer List
Table 76. Global Non-Steroidal Anti-Inflammatory API Sales Forecast by Region (2023-2028) & (Tons)
Table 77. Global Non-Steroidal Anti-Inflammatory API Sales Market Forecast by Region
Table 78. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Non-Steroidal Anti-Inflammatory API Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Americas Non-Steroidal Anti-Inflammatory API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Non-Steroidal Anti-Inflammatory API Sales Forecast by Region (2023-2028) & (Tons)
Table 83. APAC Non-Steroidal Anti-Inflammatory API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Non-Steroidal Anti-Inflammatory API Sales Forecast by Country (2023-2028) & (Tons)
Table 85. Europe Non-Steroidal Anti-Inflammatory API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Forecast by Country (2023-2028) & (Tons)
Table 87. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Non-Steroidal Anti-Inflammatory API Sales Forecast by Type (2023-2028) & (Tons)
Table 89. Global Non-Steroidal Anti-Inflammatory API Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Non-Steroidal Anti-Inflammatory API Sales Forecast by Application (2023-2028) & (Tons)
Table 93. Global Non-Steroidal Anti-Inflammatory API Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Non-Steroidal Anti-Inflammatory API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share Forecast by Application (2023-2028)
Table 96. Luan Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 97. Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
Table 98. Luan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 99. Luan Pharmaceutical Main Business
Table 100. Luan Pharmaceutical Latest Developments
Table 101. Basf Company Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 102. Basf Company Non-Steroidal Anti-Inflammatory API Product Offered
Table 103. Basf Company Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 104. Basf Company Main Business
Table 105. Basf Company Latest Developments
Table 106. Fengyuan Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 107. Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
Table 108. Fengyuan Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 109. Fengyuan Pharmaceutical Main Business
Table 110. Fengyuan Pharmaceutical Latest Developments
Table 111. Xinhua Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 112. Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
Table 113. Xinhua Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 114. Xinhua Pharmaceutical Main Business
Table 115. Xinhua Pharmaceutical Latest Developments
Table 116. Changshu Huagang Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 117. Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
Table 118. Changshu Huagang Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 119. Changshu Huagang Pharmaceutical Main Business
Table 120. Changshu Huagang Pharmaceutical Latest Developments
Table 121. Hebei Jiheng Group Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 122. Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Product Offered
Table 123. Hebei Jiheng Group Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 124. Hebei Jiheng Group Main Business
Table 125. Hebei Jiheng Group Latest Developments
Table 126. Zhejiang Kangle Group Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 127. Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Product Offered
Table 128. Zhejiang Kangle Group Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 129. Zhejiang Kangle Group Main Business
Table 130. Zhejiang Kangle Group Latest Developments
Table 131. Hebei Jingye Medical Technology Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 132. Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Product Offered
Table 133. Hebei Jingye Medical Technology Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 134. Hebei Jingye Medical Technology Main Business
Table 135. Hebei Jingye Medical Technology Latest Developments
Table 136. Hunan Middle-south Pharmaceutical Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 137. Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Product Offered
Table 138. Hunan Middle-south Pharmaceutical Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 139. Hunan Middle-south Pharmaceutical Main Business
Table 140. Hunan Middle-south Pharmaceutical Latest Developments
Table 141. Mallinckrodt Pharmaceuticals Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 142. Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Product Offered
Table 143. Mallinckrodt Pharmaceuticals Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 144. Mallinckrodt Pharmaceuticals Main Business
Table 145. Mallinckrodt Pharmaceuticals Latest Developments
Table 146. IOL Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 147. IOL Non-Steroidal Anti-Inflammatory API Product Offered
Table 148. IOL Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 149. IOL Main Business
Table 150. IOL Latest Developments
Table 151. Novacyl Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 152. Novacyl Non-Steroidal Anti-Inflammatory API Product Offered
Table 153. Novacyl Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 154. Novacyl Main Business
Table 155. Novacyl Latest Developments
Table 156. Granules India Limited Basic Information, Non-Steroidal Anti-Inflammatory API Manufacturing Base, Sales Area and Its Competitors
Table 157. Granules India Limited Non-Steroidal Anti-Inflammatory API Product Offered
Table 158. Granules India Limited Non-Steroidal Anti-Inflammatory API Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 159. Granules India Limited Main Business
Table 160. Granules India Limited Latest Developments
List of Figures
Figure 1. Picture of Non-Steroidal Anti-Inflammatory API
Figure 2. Non-Steroidal Anti-Inflammatory API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-Steroidal Anti-Inflammatory API Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Non-Steroidal Anti-Inflammatory API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non-Steroidal Anti-Inflammatory API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Aspirin
Figure 10. Product Picture of Ibuprofen
Figure 11. Product Picture of Naproxen
Figure 12. Product Picture of Diclofenac
Figure 13. Product Picture of Oxapzin
Figure 14. Product Picture of Others
Figure 15. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Type in 2021
Figure 16. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Type (2017-2022)
Figure 17. Non-Steroidal Anti-Inflammatory API Consumed in Medical Pharmaceutical
Figure 18. Global Non-Steroidal Anti-Inflammatory API Market: Medical Pharmaceutical (2017-2022) & (Tons)
Figure 19. Non-Steroidal Anti-Inflammatory API Consumed in Scientific Research
Figure 20. Global Non-Steroidal Anti-Inflammatory API Market: Scientific Research (2017-2022) & (Tons)
Figure 21. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Application (2017-2022)
Figure 22. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Application in 2021
Figure 23. Non-Steroidal Anti-Inflammatory API Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Company in 2021
Figure 25. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Geographic Region in 2021
Figure 27. Global Non-Steroidal Anti-Inflammatory API Sales Market Share by Region (2017-2022)
Figure 28. Global Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country/Region in 2021
Figure 29. Americas Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)
Figure 30. Americas Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)
Figure 31. APAC Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)
Figure 32. APAC Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)
Figure 33. Europe Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)
Figure 34. Europe Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales 2017-2022 (Tons)
Figure 36. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue 2017-2022 ($ Millions)
Figure 37. Americas Non-Steroidal Anti-Inflammatory API Sales Market Share by Country in 2021
Figure 38. Americas Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country in 2021
Figure 39. United States Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Non-Steroidal Anti-Inflammatory API Sales Market Share by Region in 2021
Figure 44. APAC Non-Steroidal Anti-Inflammatory API Revenue Market Share by Regions in 2021
Figure 45. China Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Non-Steroidal Anti-Inflammatory API Sales Market Share by Country in 2021
Figure 52. Europe Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country in 2021
Figure 53. Germany Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Non-Steroidal Anti-Inflammatory API Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Non-Steroidal Anti-Inflammatory API Revenue Market Share by Country in 2021
Figure 60. Egypt Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Non-Steroidal Anti-Inflammatory API Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Non-Steroidal Anti-Inflammatory API in 2021
Figure 66. Manufacturing Process Analysis of Non-Steroidal Anti-Inflammatory API
Figure 67. Industry Chain Structure of Non-Steroidal Anti-Inflammatory API
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.
Nanomaterials possess nanoscale dimensions ranging from 1 to 100 nanometers. They occur naturally or can be engineered with specific properties such as size, shape, surface, and chemistry. Volcanic ash and forest fibers are some of the examples of natural nano...
Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...